Our Pathbreaking Work and Tradition of Service
With our clinical work, education programs and world-class research on the nature and causes of mental illness – from addiction and schizophrenia to autism spectrum disorders – the UMass Department of Psychiatry is helping individuals and families transform their lives. We are proud of our accomplishments and pleased to be a part of the nationally ranked University of Massachusetts Medical School and UMass Memorial Health Care system.
- The department's "bench to bedside" and "bedside to community" research focuses on treatment and prevention.
- Our training programs and approach to mentoring promote excellence in teaching for future mental health care practitioners.
- Our products and services reach across the Commonwealth of Massachusetts and, now, are found in numerous sites internationally.
- Our more than 300 faculty and 2,000 staff members work in many settings within the Medical School and UMass Memorial Health Care, the public sector, and the community at large.
Douglas M. Ziedonis MD, MPH
Chairman, Dept. of Psychiatry
Latest Psychiatry Department News
Adolescent psychiatrist prescribes conservative measures before antidepressants
The college years can be stressful: More than half of college students have experienced “overwhelming anxiety” and about one-third reported they felt “so depressed that it was difficult to function” at some point during the year, according to a 2013 survey by the American College Health Association. Daniel Kirsch, MD, discusses "College kids distressed or depressed? Consider all treatment options" in this UMassMedNow article...
Stanley Medical Research Institute Grant Awarded.
Dr. Xiaoduo Fan, Associate Professor of Psychiatry and Director of the Psychotic Disorders Program was recently awarded a grant for $800,000 for 3 years for his study titled “Exenatide weekly injection as an adjunctive treatment in patients with schizophrenia” by the prestigious Stanley Medical Research Institute (SMRI). This is a 24-week, randomized, double-blind, placebo-controlled trial of exenatide weekly injection as an adjunctive therapy in 70 early phase schizophrenia subjects to examine exenatide’s effects on negative symptoms and cognition. The Stanley Medical Research Institute (SMRI) is a nonprofit organization supporting research on the causes of, and treatments for, schizophrenia and bipolar disorder. It is the largest nongovernmental source of funds for research on these diseases in the United States.
Isheeta Zalpuri, MD, was selected as one of 5 awardees to receive the American Association of Directors of Psychiatry Residency Programs (AADPRT)/International Medical Graduate Fellowship for 2014. The AADPRT International Medical Graduate Program was designed to promote the professional growth of exceptional IMG residents and fellows and facilitate their successful development as leaders.
More in the news...